Praziquantel and the control of schistosomiasis

Parasitology Today

Volumn 16, Issue 9, 2000, Pages 364-366

  Doenhoff, Mike ^a   Cioli, Donato ^b   Kimani, Gachuhi ^c  

^a BANGOR UNIVERSITY   (United Kingdom)

^b Institute of Cell Biology   (Italy)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

Author keywords

[No Author keywords available]

Indexed keywords

PRAZIQUANTEL;

AFRICA; CONFERENCE PAPER; COST; DRUG RESISTANCE; HUMAN; PREVALENCE; SCHISTOSOMIASIS;

ANTHELMINTICS; DRUG RESISTANCE; PRAZIQUANTEL; SCHISTOSOMIASIS;

EID: 0034284672     PISSN: 01694758     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-4758(00)01749-X     Document Type: Conference Paper

References (9)

1. Metwally A.et al. Impact of drug dosage and brand bioavailability and efficacy of praziquantel. Pharmacol. Res. 31:1995;53-59.
2. Kusel J., Hagan P. Praziquantel - its use, cost and possible development of resistance. Parasitol. Today. 15:1999;352-354.
3. Ismail M.et al. Characterization of isolates of Schistosoma mansoni from Egyptian villagers that tolerate high doses of praziquantel. Am. J. Trop. Med. Hyg. 55:1996;212-218.
4. Ismail M.et al. Resistance to praziquantel: Direct evidence from Schistosoma mansoni isolated from Egyptian villagers. Am. J. Trop. Med. Hyg. 60:1999;932-935.
5. Renganathan E., Cioli D. An international initiative on praziquantel use. Parasitol. Today. 14:1998;390-391.
6. Fallon P.G., Doenhoff M.J. Drug-resistant schistosomiasis. Resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific Am. J. Trop. Med. Hyg. 51:1994;83-89.
7. Liang Y.S.et al. Detection of praziquantel resistance in schistosomes. Trop. Med. Int. Hlth. 5:2000;72.
8. Utzinger J.et al. Oral artemether for prevention of Schistosoma mansoni infection: randomised controlled trial. Lancet. 355:2000;1320-1325.
9. Bout D.T.et al. Antischistosomal effect of cyclosporin A: cure and prevention of mouse and rat schistosomiasis mansoni. Infect. Immun. 52:1986;823-827.